Cancer Powered by Trendolizer

Reuters | Shire , the London-listed rare diseases specialist that...

Trending story found on www.facebook.com
Reuters | Shire , the London-listed rare diseases specialist that...
Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for...
[Source: www.facebook.com] [ Comments ] [See why this is trending]

Trend graph:

Comments